Dr. Farnaz Farid | Healthcare industry | Best Researcher Award

Published on by AI Data Scientist

Dr. Farnaz Farid | Healthcare industry | Best Researcher Award

Multidisciplinary Researcher, Western Sydney University, Australia

Dr. Farnaz Farid is a distinguished and multidisciplinary researcher whose academic journey and professional experience span industry and academia, combining expertise in artificial intelligence, cybersecurity, human-centered systems, and applied computing. She holds a Doctor of Philosophy (PhD) degree from Western Sydney University, where her doctoral research focused on computational modeling, AI-driven predictive systems, and network quality of service frameworks; she also earned earlier degrees in engineering and computing from reputable institutions that shaped her foundation in IT, networks, and systems. Over the years, Dr. Farnaz Farid has served in both industry and academic roles: prior to joining academia, she worked at IBM as an IT Specialist, Application Developer, and Project Manager, contributing to enterprise integration, software development, and digital innovation; subsequently, she entered academia as an Associate Lecturer at the University of Sydney and then moved to Western Sydney University, where she is now a Senior Lecturer and Academic Program Advisor, co-leading global initiatives such as “Realising Digital Futures.” Her professional experience includes overseeing cross-disciplinary projects in AI, cybersecurity, IoT, and smart systems, mentoring postgraduate researchers, guiding curriculum development, and fostering partnerships with industry and community stakeholders. Her research interests encompass explainable AI, human-centred security, AI for healthcare, cyber‐physical systems, distributed networks, federated learning, and digital inclusion. Dr. Farid has received a number of awards and honors, such as the Google exploreCSR grant over multiple years to lead community‐based AI projects, the DVC Education Excellence in Teaching (Partnerships) award at her university, and the Teaching and Learning for Public Good Award in Social Sciences, all of which attest to her excellence in teaching, public engagement, and socially impactful research. Through her editorial service (for journals such as Symmetry and Sustainability), membership in the Asian Council of Science Editors (ACSE), and leadership of cross‐disciplinary grants, she has also contributed to the scientific community.

Profile: GOOGLE SCHOLAR  | SCOPUS | ORCID

Featured Publications

  • Farid, F. (2025). An explainable predictive model for the detection of mental health conditions in the workplace. (citation count: 13)

  • Farid, F. (2025). A threat analysis framework for cyberattacks in smart cities: ransomware in focus. (citation count: 24)

  • Dong, H., & Farid, F. (2024). A deep learning based patient care application for skin cancer detection.

  • Farid, F., & colleagues. (2024). AI technologies in reducing hospital readmission for chronic diseases: a recommended framework.

  • Lai, T., & Farid, F. (2024). Ensemble learning for IoT cybersecurity via Bayesian hyperparameters sensitivity analysis.

Nidha Shapoo | Digital Health | Best Academic Researcher Award

Published on by AI Data Scientist

Dr. Nidha Shapoo | Digital Health | Best Academic Researcher Award

Resident Physician at New York Medical College/Metropolitan Hospital, United States

Dr. Nidha Shapoo is a highly accomplished physician-researcher with a proven track record in oncology and internal medicine. Having served in diverse healthcare systems including India, UAE, Saudi Arabia, and the USA, she brings a global perspective to patient care and academic research. Her clinical and academic journey is driven by a passion for evidence-based medicine, multidisciplinary collaboration, and scholarly output.

👩‍⚕️ Profile

Scopus

ORCID

Google Scholar

✅ Best Academic Researcher Award

Dr. Nidha Shapoo emerges as an exceptional candidate for the Best Academic Researcher Award, given her outstanding contributions to the fields of hematology-oncology and internal medicine across multiple countries. Her extensive clinical background, academic excellence, and prolific publication record make her highly deserving of this recognition. With active roles in research, mentoring, quality improvement, and editorial work, she upholds the spirit of academic advancement and medical innovation.

🎓 Education

Her academic pathway includes an MBBS and MD in Internal Medicine from the University of Jammu, a DM in Hematology-Oncology from the prestigious All India Institute of Medical Sciences (AIIMS), and a Specialty Certificate in Medical Oncology from the Federation of the Royal College of Physicians (UK). She is currently completing her Internal Medicine residency at New York Medical College/Metropolitan Hospital, USA.

🩺 Experience

Dr. Shapoo has accumulated rich professional experience as a hematology-oncology consultant in India, UAE, and Saudi Arabia. Her current role as a resident physician in internal medicine in the USA showcases her ongoing commitment to clinical excellence and academic growth. She has also mentored junior doctors, presented at conferences, and led complex oncology cases through tumor boards and multidisciplinary teams.

🔬 Research Interest

Her research interests span a wide spectrum of oncology and internal medicine domains, including hematologic malignancies, solid tumors, supportive care, digital health, and patient safety. She is particularly noted for her work on soft tissue sarcomas, coagulopathy in cancer, health equity, and interdisciplinary management of complex cases. Her focus on evidence-based care aligns perfectly with the goals of academic medicine.

📚 Publications

Dr. Shapoo has published over 30 peer-reviewed articles in respected journals, many of which are indexed in PubMed and Google Scholar. She has co-authored high-impact studies, clinical trials, and case reports, contributing significantly to both theoretical and applied aspects of oncology. Her HER2 review article alone has received over 1500 citations.

📝 Selected Publications:

  1. Solid Tumors, Liquid Challenges – Hematology Reports, 2025

  2. Smart Healthcare – Healthcare Science, 2025

  3. Lost in the Mix: Myxedema Coma – J Clin Images Med Case Rep, 2025

  4. Resistance in Prostate Cancer – J Clin Trials, 2024

  5. Navigating Cancer Journeys – J Clin Exp Oncol, 2024

  6. Red Cell Distribution Width in Hematologic Disorders – Am J Biomed Sci & Res, 2024

  7. Oncologists – Bearers of News – Indian Journal of Cancer, 2024

  8. Human Epidermal Growth Factor Receptor 2 (HER2) – Mol Biol Int, 2014

  9. Imatinib in Cancer Therapy – Chemother Res Pract, 2014

  10. Prognostic Factors in Soft Tissue Sarcoma – Clin Transl Oncol, 2016

🏁 Conclusion

Dr. Nidha Shapoo’s unwavering dedication to medical research, her global clinical experience, and her prolific contributions to oncology literature distinctly position her as a front-runner for the Best Academic Researcher Award. Her scholarly depth, collaborative spirit, and continuous pursuit of medical excellence exemplify the ideals this award seeks to honor.

Ben Ke | Treatment of disease | Best Scholar Award

Published on by AI Data Scientist

Dr. Ben Ke | Treatment of disease | Best Scholar Award

PI at The Second Affiliated Hospital of Nanchang University, China

Ben Ke is a dedicated researcher and academic in the field of nephrology, with a strong background in clinical medicine and molecular research. His work primarily focuses on kidney disease, inflammation, and fibrosis, contributing to the understanding and potential treatment of renal conditions. Through his extensive research, he has explored key cellular mechanisms involved in kidney pathology and has made significant contributions to the scientific community. With a strong foundation in both experimental and scientific writing skills, Ben Ke has been involved in high-impact research, publications, and collaborations that advance the medical field.

Profile

Scopus

Education

Ben Ke pursued his undergraduate education in Clinical Medicine at Gannan Medical University from 2008 to 2013, earning a Bachelor’s degree. His strong interest in nephrology led him to further specialize in this domain, obtaining a Master’s degree from Nanchang University between 2013 and 2016. His academic journey equipped him with a robust knowledge of kidney disease pathophysiology and therapeutic strategies. Throughout his educational years, he honed his research capabilities and developed expertise in experimental techniques crucial for investigating renal disorders.

Experience

With a strong foundation in nephrology and molecular medicine, Ben Ke has gained valuable experience in both laboratory research and clinical applications. His expertise in experimental techniques such as Western Blot, Q-PCR, cell culture, and plasmid transfection has enabled him to conduct in-depth studies on renal fibrosis, inflammation, and metabolic disorders affecting kidney function. His ability to write scientific papers and secure research funding highlights his proficiency in the academic and research domain. He has also successfully collaborated with various experts in the field to publish high-impact studies, contributing valuable insights into kidney disease mechanisms and therapeutic approaches.

Research Interest

Ben Ke’s research interests revolve around nephrology, with a particular focus on inflammation, fibrosis, and metabolic disturbances in kidney disease. He has extensively studied the role of the NLRP3 inflammasome in obesity-related kidney disease and the impact of endoplasmic reticulum stress on renal fibrosis. His investigations into matrix metalloproteinases and their role in kidney fibrosis have provided deeper insights into disease progression and potential treatment strategies. By exploring cellular signaling pathways and molecular mechanisms, he aims to contribute to the development of innovative therapeutic interventions for kidney-related disorders.

Awards and Certifications

Ben Ke has demonstrated exceptional academic and research capabilities, earning recognition for his contributions to the field of nephrology. He has received the College English Test-6 Certificate, showcasing his proficiency in scientific communication. Additionally, his Certificate of Clinical Competence underscores his ability to apply his knowledge effectively in clinical and research settings. His dedication to nephrology research and his expertise in scientific methodologies make him a strong candidate for awards and further recognition in his field.

Publications

Ke B, Shen W, Fang X, Wu Q. “The NLPR3 inflammasome and obesity-related kidney disease.” Journal of Cellular and Molecular Medicine, 2017. Cited by multiple studies exploring inflammation in renal pathology.

Ke B, Zhu N, Luo F, Xu Y, Fang X. “Targeted inhibition of endoplasmic reticulum stress: New hope for renal fibrosis (Review).” Molecular Medicine Reports, 2017;16(2):1014-1020. Widely referenced in fibrosis-related research.

Ke B, Fan C, Yang L, Fang X. “Matrix Metalloproteinases-7 and Kidney Fibrosis.” Frontiers in Physiology, 2017;8:21. Cited for its insights into kidney fibrosis mechanisms.

Ke B, Zhang A, Wu X, Fang X. “The Role of Kruppel-like Factor 4 in Renal Fibrosis.” Frontiers in Physiology, 2015;6:327. Recognized for its contribution to renal disease research.

Conclusion

Ben Ke is an accomplished researcher with a strong academic background and expertise in nephrology. His research contributions have significantly advanced the understanding of kidney disease mechanisms, particularly in inflammation and fibrosis. With a solid foundation in experimental skills, scientific writing, and clinical competence, he continues to contribute to the medical community through impactful research and publications. His dedication to nephrology research highlights his commitment to improving treatment strategies and advancing knowledge in the field of renal medicine.